ArticleThrombosis journal2026

Hematologic safety of caplacizumab in immune-mediated thrombotic thrombocytopenic purpura: insights from platelet-related signal detection in the FAERS database.

Zhenqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.